BioWorld MedTech

April 14, 2014

View Archived Issues

New Boston Sci registry to evaluate Vercise DBS in Parkinson's patients

Boston Scientific (Natick, Massachusetts) has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Vercise deep brain stimulation (DBS) system in patients with Parkinson's disease. Read More

Report from Israel: Nazareth incubator NGT3 raising funds with lofty dual agenda

Read More

Washington Roundup: FDA nod to Block HF adds 800K to market for biventricular pacing

Read More

MDD's Stock Watch

Read More

Report from Europe: Focus shifts from sales to costs for French startups

Read More

Court Report: Varian settles patent litigation with University of Pittsburgh for $35M

Read More

Deals Roundup: Covidien in plan to acquire New Wave Surgical for $100M

Read More

Report from Europe: Seno awarded CE mark for Imagio imaging system

Read More

Financings roundup: Ventas prices public offering of senior notes

Read More

Sebelius out at HHS, but Burwell unlikely to steer different course

Read More

People in Places

Read More

Briefly Noted

Read More

Product briefs

Read More

MDD's Neurology Extra

Read More